Discuss the potential of RNA editing in treating genetic disorders. How does it differ from DNA editing in terms of safety and efficacy?
Kartavya Desk Staff
Topic. : Awareness in Bio-Tech
Topic. : Awareness in Bio-Tech
Q6. Discuss the potential of RNA editing in treating genetic disorders. How does it differ from DNA editing in terms of safety and efficacy? (10 M)
Difficulty Level: Difficult
Reference: TH
Why the Question A biotechnology company named Wave Life Sciences made headlines for becoming the first company to treat a genetic condition by editing RNA at the clinical level. Key Demand of the Question Describe the potential applications of RNA editing in treating genetic disorders. Explain differences between RNA and DNA editing with respect to safety and efficacy. Structure of the Answer Introduction Briefly introduce RNA editing and its emerging role in gene therapy for genetic disorders. Body *Potential of RNA Editing: Outline the ability of RNA editing to treat conditions by correcting mRNA errors without altering the DNA. Differences in Safety and Efficacy: Explain how RNA editing is generally safer due to its temporary effects and lower immune response, while DNA editing is more permanent and potentially riskier but has a lasting impact. Conclusion* Conclude with a brief note on the promise of RNA editing as a flexible, reversible approach for gene therapy with an emphasis on patient safety.
Why the Question
A biotechnology company named Wave Life Sciences made headlines for becoming the first company to treat a genetic condition by editing RNA at the clinical level.
Key Demand of the Question
Describe the potential applications of RNA editing in treating genetic disorders. Explain differences between RNA and DNA editing with respect to safety and efficacy.
Structure of the Answer
Introduction
Briefly introduce RNA editing and its emerging role in gene therapy for genetic disorders.
• *Potential of RNA Editing*: Outline the ability of RNA editing to treat conditions by correcting mRNA errors without altering the DNA.
• *Differences in Safety and Efficacy*: Explain how RNA editing is generally safer due to its temporary effects and lower immune response, while DNA editing is more permanent and potentially riskier but has a lasting impact.
Conclusion
Conclude with a brief note on the promise of RNA editing as a flexible, reversible approach for gene therapy with an emphasis on patient safety.